|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.405 USD | +1.48% |
|
-0.21% | +33.61% |
| 13/05 | Protalix BioTherapeutics, Inc., Q1 2026 Earnings Call, May 13, 2026 | |
| 13/05 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Quotes 5-day view: Protalix BioTherapeutics, Inc.
Delayed Quote NYSE
| 21/07/2026 | 22/07/2026 | 23/07/2026 | 24/07/2026 | 27/07/2026 | |
|---|---|---|---|---|---|
| Last | $2.360 | $2.370 | $2.370 | $2.370 | $2.410 |
| Volume | 5,19,945 | 2,76,755 | 4,49,023 | 2,12,184 | 3,98,947 |
| Change | -2.07% | +0.42% | 0.00% | 0.00% | +1.48% |
| Opening | $2.420 | $2.340 | $2.340 | $2.350 | $2.390 |
| High | $2.420 | $2.390 | $2.385 | $2.390 | $2.460 |
| Low | $2.340 | $2.310 | $2.315 | $2.330 | $2.360 |
Performance
| 1 day | +1.48% | ||
| 1 week | -0.21% | ||
| Current month | +3.22% | ||
| 1 month | +2.34% | ||
| 3 months | +11.34% | ||
| 6 months | +13.44% | ||
| Current year | +33.61% | ||
| 1 year | +60.33% | ||
| 3 years | +44.01% | ||
| 5 years | +55.16% | ||
| 10 years | -63.56% |
Volumes
marketsDaily volume
3,98,947
Estimated daily volume
5,82,695
Avg. Volume 20 sessions
5,31,209
Daily volume ratio
1.1
Avg. Volume 20 sessions USD
12,77,557.65
Record volume 1
19,12,89,000
Record volume 2
1,94,14,390
Record volume 3
1,27,16,823
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (USD)
19,09,54,791
Net sales (USD)
5,27,44,000
Number of employees
226
Sales / Employee (USD)
2,33,381
Free-Float
96.12 %
Free-Float capitalization (USD)
18,35,49,954
Average Daily Capital Traded
0.67%
Indicators
Moving average 5 days
2.376
Moving average 20 days
2.345
Moving average 50 days
2.163
Moving average 100 days
2.238
Price spread / (MMA5)
-1.21%
Price spread / (MMA20)
-2.49%
Price spread / (MMA50)
-10.08%
Price spread / (MMA100)
-6.93%
STIM
RSI 9 days
56.47
RSI 14 days
57.81
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.48% | -0.21% | +60.33% | +44.01% | 19Cr | |
| +0.10% | +4.36% | +48.12% | +163.07% | 1,06700Cr | |
| +1.67% | +7.62% | +61.10% | +54.17% | 63TCr | |
| -0.40% | +1.99% | +37.07% | +73.60% | 46TCr | |
| +1.41% | +8.56% | +38.18% | +32.17% | 35TCr | |
| +1.28% | +4.40% | +37.69% | +41.62% | 30TCr | |
| +1.72% | +4.10% | +19.44% | +20.45% | 26TCr | |
| +1.84% | -0.46% | -27.63% | -38.65% | 22TCr | |
| +0.26% | +3.33% | +24.90% | +59.42% | 20TCr | |
| +1.51% | -1.57% | +16.00% | +71.38% | 16TCr | |
| Average | +1.22% | +1.15% | +31.52% | +52.12% | 36.44TCr | |
| Weighted average by Cap. | +0.92% | +1.95% | +37.94% | +78.50% |
Historical Quotes: Protalix BioTherapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
4906786d2a09696dac2f4b.NSKexfkzeeKWj3XJ2uI2sZU9uYfYAHSDoNzJMocyym4.ZEb1pK9eOI7T2jiQioZ_5-ME7MC5aRLA9qXwd_B5iBcDZ-2Av2Ez2tPZOA
| Date | Price | Volume | Total |
|---|---|---|---|
| 11:26:59 pm | 2.410 | 200 | 3,66,552 |
| 11:26:59 pm | 2.410 | 100 | 3,66,352 |
| 11:26:59 pm | 2.410 | 207 | 3,66,252 |
| 11:26:57 pm | 2.415 | 400 | 3,66,045 |
| 11:26:56 pm | 2.415 | 300 | 3,65,645 |
| 11:26:56 pm | 2.415 | 500 | 3,65,345 |
| 11:26:56 pm | 2.415 | 100 | 3,64,845 |
| 11:26:56 pm | 2.415 | 100 | 3,64,745 |
| 11:26:56 pm | 2.415 | 100 | 3,64,645 |
| 11:26:56 pm | 2.415 | 100 | 3,64,545 |
Course Extremes
| 1 week | 2.31 |  | 2.46 |
| 1 month | 2.25 | | 2.48 |
| Current year | 1.72 | | 3.19 |
| 1 year | 1.41 | | 3.19 |
| 3 years | 0.82 | | 3.19 |
| 5 years | 0.7 | | 3.55 |
| 10 years | 0.7 | | 15.15 |
Monthly variations
Annual variations
| 2026 | +31.67% | ||
| 2025 | -4.26% | ||
| 2024 | +5.62% | ||
| 2023 | +29.93% | ||
| 2022 | +64.72% | ||
| 2021 | -77.09% | ||
| 2020 | +10.67% | ||
| 2019 | +5.47% | ||
| 2018 | -52.96% | ||
| 2017 | +48.58% | ||
| 2016 | -56.37% | ||
| 2015 | -44.57% | ||
| 2014 | -52.70% | ||
| 2013 | -25.05% | ||
| 2012 | +5.27% | ||
| 2011 | -50.60% | ||
| 2010 | +50.76% | ||
| 2009 | +259.78% | ||
| 2008 | -45.88% | ||
| 2007 | -87.48% |
- Stock Market
- Stocks
- PLX Stock
- Quotes Protalix BioTherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
